Literature DB >> 10594548

Cytokines in experimental colitis.

P Garside.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10594548      PMCID： PMC1905439          DOI： 10.1046/j.1365-2249.1999.01088.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  34 in total

1.  IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

Authors:  T Hoshino; R H Wiltrout; H A Young
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 2.  Cytokines induce the development of functionally heterogeneous T helper cell subsets.

Authors:  A O'Garra
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

3.  Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma.

Authors:  M Tsujimoto; J Vilcek
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

4.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

5.  Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis.

Authors:  F Mackay; J L Browning; P Lawton; S A Shah; M Comiskey; A K Bhan; E Mizoguchi; C Terhorst; S J Simpson
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

6.  Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.

Authors:  Y Chen; J Inobe; V K Kuchroo; J L Baron; C A Janeway; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

7.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

8.  IL-4-regulated enteropathy in an intestinal nematode infection.

Authors:  C E Lawrence; J C Paterson; L M Higgins; T T MacDonald; M W Kennedy; P Garside
Journal:  Eur J Immunol       Date:  1998-09       Impact factor: 5.532

9.  Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells.

Authors:  A Iwasaki; B L Kelsall
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

10.  Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells.

Authors:  N Corazza; S Eichenberger; H P Eugster; C Mueller
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307
View more
  18 in total

1.  Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.

Authors:  Ning Lu; Lihong Wang; Hailong Cao; Liping Liu; Luc Van Kaer; Mary K Washington; Michael J Rosen; Philip E Dubé; Keith T Wilson; Xiubao Ren; Xishan Hao; D Brent Polk; Fang Yan
Journal:  J Immunol       Date:  2014-01-03       Impact factor: 5.422

2.  Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis.

Authors:  Kazunori Fujino; Yoji Takami; Sebastian G de la Fuente; Kirk A Ludwig; Christopher R Mantyh
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

3.  Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice.

Authors:  Fang Yan; Lihong Wang; Yan Shi; Hanwei Cao; Liping Liu; M Kay Washington; Rupesh Chaturvedi; Dawn A Israel; Hailong Cao; Bangmao Wang; Richard M Peek; Keith T Wilson; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-15       Impact factor: 4.052

4.  VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.

Authors:  Silvia D'Alessio; Carmen Correale; Carlotta Tacconi; Alessandro Gandelli; Giovanni Pietrogrande; Stefania Vetrano; Marco Genua; Vincenzo Arena; Antonino Spinelli; Laurent Peyrin-Biroulet; Claudio Fiocchi; Silvio Danese
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

5.  CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.

Authors:  Marc-Andre Wurbel; Maria G McIntire; Peter Dwyer; Edda Fiebiger
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

6.  Alpinetin attenuates inflammatory responses by suppressing TLR4 and NLRP3 signaling pathways in DSS-induced acute colitis.

Authors:  Xuexiu He; Zhengkai Wei; Jingjing Wang; Jinhua Kou; Weijian Liu; Yunhe Fu; Zhengtao Yang
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

7.  Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease.

Authors:  Jin Seok Park; Tac-Ghee Yi; Jong-Min Park; Young Min Han; Jun-Hyung Kim; Dong-Hee Shin; Seon Ji Tak; Kyuheon Lee; Youn Sook Lee; Myung-Shin Jeon; Ki-Baik Hahm; Sun U Song; Seok Hee Park
Journal:  J Clin Biochem Nutr       Date:  2015-10-21       Impact factor: 3.114

8.  Tristetraprolin mediates anti-inflammatory effect of carbon monoxide against DSS-induced colitis.

Authors:  Yeonsoo Joe; Md Jamal Uddin; Min Zheng; Hyo Jeong Kim; Yingqing Chen; Nal Ae Yoon; Gyeong Jae Cho; Jeong Woo Park; Hun Taeg Chung
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

9.  GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway.

Authors:  Yue Zhao; Yang Sun; Youxiang Ding; Xiaoping Wang; Yuxin Zhou; Wenjun Li; Shaoliang Huang; Zhiyu Li; Lingyi Kong; Qinglong Guo; Na Lu
Journal:  Oncotarget       Date:  2015-09-22

10.  Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood.

Authors:  F Yan; L Liu; H Cao; D J Moore; M K Washington; B Wang; R M Peek; S A Acra; D B Polk
Journal:  Mucosal Immunol       Date:  2016-04-20       Impact factor: 7.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.